We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.
Scientists at the Institute of Cancer Research (ICR) in the UK have found that inhibition of the cyclin G associated kinase (GAK) protein has the potential to allow treatment of different types of cancer.